Skip to main content
logo
Nu-Med Plus, Inc. (NUMD)
OTCMKTS · Delayed Price · Currency is USD
0.0146
0.00 (0.00%)
Sep 30, 2026, 4:00 PM EST

Nu-Med Plus Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
0.060.050.060.120.180.83
Operating Expenses
0.060.050.060.120.180.84
Operating Income
-0.06-0.05-0.06-0.12-0.18-0.84
Interest Expense
-0.01-0.01-0.01-0.01-0-
Other Non Operating Income (Expenses)
0.05-----
EBT Excluding Unusual Items
-0.02-0.06-0.07-0.13-0.18-0.84
Gain (Loss) on Sale of Assets
----0-
Other Unusual Items
----0.050.01
Pretax Income
-0.02-0.06-0.07-0.13-0.13-0.83
Net Income
-0.02-0.06-0.07-0.13-0.13-0.83
Net Income to Common
-0.02-0.06-0.07-0.13-0.13-0.83
Net Income Growth
------
Shares Outstanding (Basic)
848484828073
Shares Outstanding (Diluted)
848484828073
Shares Change
--2.30%2.15%8.96%34.60%
EPS (Basic)
-0.00-0.00-0.00-0.00-0.00-0.01
EPS (Diluted)
-0.00-0.00-0.00-0.00-0.00-0.01
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-0.05-0.05-0-0.07-0.04-0.21
Free Cash Flow Per Share
-0.00-0.00--0.00--0.00
EBITDA
----0.12-0.18-0.83
D&A For EBITDA
---000.01
EBIT
-0.06-0.05-0.06-0.12-0.18-0.84